Literature DB >> 16918689

Regulatory T cells and systemic lupus erythematosus.

P A Mudd1, B N Teague, A D Farris.   

Abstract

CD4+CD25+ regulatory T cells (Treg) constitute an important mechanism of peripheral immune tolerance. Organ-specific autoimmune conditions, such as thyroiditis and insulin-dependent diabetes mellitus have been attributed to a breakdown of this tolerance mechanism. However, this T-cell subset has not been well studied in patients and mice with systemic lupus erythematosus (SLE; lupus). The information that has been gathered so far using new tools that discriminate Treg from activated T cells indicates that reduced numbers of Treg may exist in patients with lupus. In addition, potential defects in SLE Treg function have been documented in humans and mice. Our group has demonstrated equivalent proportions of thymic Treg in lupus prone and normal mice. We therefore propose that Treg function in SLE is the more important factor to address in future studies of murine lupus. Recent studies have shown that Toll-like receptor (TLR) ligation can result in an abrogation of Treg-mediated suppression; specifically ligation of TLR-2, -4, -8 and -9. We address this new information about TLRs and Treg and propose a model for Treg tolerance breakdown to nucleic acid-binding SLE autoantigens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16918689     DOI: 10.1111/j.1365-3083.2006.01808.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

1.  Inhibition of osteoclast differentiation and matrix metalloproteinase production by CD4+CD25+ T cells in mice.

Authors:  P T Yang; X H Meng; Y Yang; W G Xiao
Journal:  Osteoporos Int       Date:  2012-05-23       Impact factor: 4.507

Review 2.  Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone mice.

Authors:  Brian J Skaggs; Ram Pyare Singh; Bevra H Hahn
Journal:  Hum Immunol       Date:  2008-09-24       Impact factor: 2.850

3.  Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development.

Authors:  Diana Milojevic; Khoa D Nguyen; Diane Wara; Elizabeth D Mellins
Journal:  Pediatr Rheumatol Online J       Date:  2008-12-01       Impact factor: 3.054

4.  The role of regulatory T cells in cancer.

Authors:  Tai-You Ha
Journal:  Immune Netw       Date:  2009-12-31       Impact factor: 6.303

5.  The regulation of autoreactive B cells during innate immune responses.

Authors:  Barbara J Vilen; Jennifer A Rutan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

6.  The Role of MicroRNAs in Regulatory T Cells and in the Immune Response.

Authors:  Tai-You Ha
Journal:  Immune Netw       Date:  2011-02-28       Impact factor: 6.303

7.  CD4+CD25(high), CD8+CD28- cells and thyroid autoantibodies in breast cancer patients.

Authors:  Oğuz Biylgi; Bülent Karagöz; Orhan Türken; Mustafa Gültepe; Alpaslan Özgün; Tolga Tunçel; Levent Emirzeoğlu; Serkan Çelik; Tuba Müftüoğlu; Emin Gökhan Kandemir
Journal:  Cent Eur J Immunol       Date:  2014-10-14       Impact factor: 2.085

Review 8.  Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies.

Authors:  Xiaoyu Wang; Yumin Xia
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.